Novel discoveries targeting gemcitabine‐based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?

Pancreatic cancer (PC) remains one of the deadliest malignancies worldwide. Chemoresistance is a significant clinical problem in pancreatic ductal adenocarcinoma (PDAC) and numerous potential mechanisms have been demonstrated but much remains to be understood. To overcome the existing limitations in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Luo, Wenhao, Yang, Gang, Qiu, Jiangdong, Luan, Jingyang, Zhang, Ying, You, Lei, Feng, Mengyu, Zhao, Fangyu, Liu, Yueze, Cao, Zhe, Zheng, Lianfang, Zhang, Taiping, Zhao, Yupei
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Cancer Prevention
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6797580/
https://ncbi.nlm.nih.gov/pubmed/31475468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2384
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados